The Bumpy Road To Approving New Alzheimers Drugs
After a controversial Alzheimer\u2019s medication was discontinued, a new anti-amyloid drug receives extra scrutiny from the FDA.
After a controversial Alzheimer\u2019s medication was discontinued, a new anti-amyloid drug receives extra scrutiny from the FDA.